In this video, Motley Fool health care analyst David Williamson gives us the story behind two big biotech jumps today and two big stumbles. Sequenom (NAS: SQNM) continues its rally from Friday with more good news that its RetnaGene AMD accurately predicts the progression of wet age-related macular degeneration; this has shares up an additional 8% on top of Friday's 19%. Repros Therapeutics (NAS: RPRX) also up today ahead of presenting both of its phase 2 drugs, Androxal and Proellex, at the Lazard conference tomorrow. Meanwhile, Cyclacel (NAS: CYCC) and Transcept (NAS: TSPT) are both down today after disappointing earnings releases.
While you can certainly make huge gains in biotech and pharmaceuticals when these stocks make big jumps, the best investing approach is to choose great companies and stick with them for the long term. In our free report "3 Stocks That Will Help You Retire Rich," we name stocks that could help you build long-term wealth and retire well, along with some winning wealth-building strategies that every investor should be aware of. Click here now to keep reading.
The article 4 Biotechs' Dominant Moves originally appeared on Fool.com.
David Williamson has no positions in the stocks mentioned above. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.